Work

Supplementary Table S1 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET

Year: 2025

Type: supplementary-materials

Abstract: Tumor-to-tissue ratios of Al[18F]F-ssHN3 in orthotopic HepG2 liver cancer model calculated from ex vivo biodistribution (n = 4 / time point).

DOI: 10.1158/1078-0432.30882829

Authors: Stanley Fayn, Woonghee Lee, Falguni Basuli, Jianfeng Shi, Hima Makala, Joon-Yong Chung, Dan Li, Divya Nambiar, Jesse Buffington, Robert Morhard, Colleen P. Olkowski, Orit Jacobson, Bradford J. Wood, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke, Freddy E. Escorcia

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4417314494

Cites:

Cited by:

Related to: